MediPharm Labs (T:LABS) has notable insider buying

Braden William Fenske, a Senior Officer, acquired 9,009 Common Shares on a direct ownership basis at a price of $5.420 through a prospectus or prospectus exempt offering on June 17th, 2019. This represents a $48,829 investment into the company's shares and an account share holdings change of greater than 100%.

MediPharm Labs is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Medipharm Labs Corp, formerly known as POCML 4 Inc, is a Canada-based medicinal cannabis company specializing in the pharmaceutical grade production of cannabis. The Company is focused on distillation and cannabinoid isolation and purification. The Company actively builds an inventory of specialized consumer products in anticipation of federal legalization of the adult-use market in Canada. Outside of the Canadian market, the Company develops MediPharm Labs Australia facility, which is a purpose-built and component of the Company's international investments. The Company operates with a processing capacity of approximately 100,000 kilograms of dry cannabis flower and trim per year.